Historical Stock Price
|
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ABEO Historical Stock Prices |
| Preferred Stock Newsletter |
| ABEO Options Chain |
| Stock Message Boards |
Abeona Therapeutics (ABEO) has the following price history information. Looking back at ABEO historical stock prices for the last five trading days, on October 17, 2019, ABEO opened at $2.39, traded as high as $2.50 and as low as $2.21, and closed at $2.26. Trading volume was a total of 724.20K shares. On October 18, 2019, ABEO opened at $2.22, traded as high as $2.39 and as low as $2.11, and closed at $2.17. Trading volume was a total of 584.70K shares. On October 21, 2019, ABEO opened at $2.16, traded as high as $2.30 and as low as $2.12, and closed at $2.26. Trading volume was a total of 385.30K shares. On October 22, 2019, ABEO opened at $2.27, traded as high as $2.45 and as low as $2.27, and closed at $2.39. Trading volume was a total of 373.10K shares. On October 23, 2019, ABEO opened at $2.39, traded as high as $2.50 and as low as $2.30, and closed at $2.39. Trading volume was a total of 274.20K shares.
ABEO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abeona Therapeutics shares, starting with a $10,000 purchase of ABEO, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 10/23/2009 | |
| End date: | 10/23/2019 | |
| Start price/share: | $3.35 | |
| End price/share: | $2.39 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -28.66% | |
| Average Annual Total Return: | -3.32% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $7,133.23 | |
| Years: | 10.01 | |
 | |||||
| ABEO Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 10/17/2019 | $2.39 | $2.50 | $2.21 | $2.26 | 724.20K |
| 10/18/2019 | $2.22 | $2.39 | $2.11 | $2.17 | 584.70K |
| 10/21/2019 | $2.16 | $2.30 | $2.12 | $2.26 | 385.30K |
| 10/22/2019 | $2.27 | $2.45 | $2.27 | $2.39 | 373.10K |
| 10/23/2019 | $2.39 | $2.50 | $2.30 | $2.39 | 274.20K |
|
| About Abeona Therapeutics |
| Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s main programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa, ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A, and ABO-101 an AAV-based gene therapy for Sanfilippo syndrome type B. Co. is also developing ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten Disease, respectively, ABO-401 for the treatment of cystic fibrosis, and ABO-5OX for the treatment of retinal diseases. |
| ABEO Historical Closing Prices | |
| Date | Close |
| 10/17/2019 | $2.26 |
| 10/18/2019 | $2.17 |
| 10/21/2019 | $2.26 |
| 10/22/2019 | $2.39 |
| 10/23/2019 | $2.39 |
| Healthcare Historical Prices |
| ABEO is categorized under the Healthcare sector; below are some other companies in the same sector:
ABIO Historical Stock Prices Also explore: ABEO shares outstanding history |
